Literature DB >> 22072784

Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques.

Hiroshi Ishii1, Miki Kawada, Tetsuo Tsukamoto, Hiroyuki Yamamoto, Saori Matsuoka, Teiichiro Shiino, Akiko Takeda, Makoto Inoue, Akihiro Iida, Hiroto Hara, Tsugumine Shu, Mamoru Hasegawa, Taeko K Naruse, Akinori Kimura, Masafumi Takiguchi, Tetsuro Matano.   

Abstract

Cytotoxic T lymphocyte (CTL) responses play a central role in viral suppression in human immunodeficiency virus (HIV) infections. Prophylactic vaccination resulting in effective CTL responses after viral exposure would contribute to HIV control. It is important to know how CTL memory induction by vaccination affects postexposure CTL responses. We previously showed vaccine-based control of a simian immunodeficiency virus (SIV) challenge in a group of Burmese rhesus macaques sharing a major histocompatibility complex class I haplotype. Gag(206-216) and Gag(241-249) epitope-specific CTL responses were responsible for this control. In the present study, we show the impact of individual epitope-specific CTL induction by prophylactic vaccination on postexposure CTL responses. In the acute phase after SIV challenge, dominant Gag(206-216)-specific CTL responses with delayed, naive-derived Gag(241-249)-specific CTL induction were observed in Gag(206-216) epitope-vaccinated animals with prophylactic induction of single Gag(206-216) epitope-specific CTL memory, and vice versa in Gag(241-249) epitope-vaccinated animals with single Gag(241-249) epitope-specific CTL induction. Animals with Gag(206-216)-specific CTL induction by vaccination selected for a Gag(206-216)-specific CTL escape mutation by week 5 and showed significantly less decline of plasma viral loads from week 3 to week 5 than in Gag(241-249) epitope-vaccinated animals without escape mutations. Our results present evidence indicating significant influence of prophylactic vaccination on postexposure CTL immunodominance and cooperation of vaccine antigen-specific and non-vaccine antigen-specific CTL responses, which affects virus control. These findings provide great insights into antigen design for CTL-inducing AIDS vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072784      PMCID: PMC3255834          DOI: 10.1128/JVI.06226-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.

Authors:  Marcus Altfeld; Marylyn M Addo; Eric S Rosenberg; Frederick M Hecht; Paul K Lee; Martin Vogel; Xu G Yu; Rika Draenert; Mary N Johnston; Daryld Strick; Todd M Allen; Margaret E Feeney; James O Kahn; Rafick P Sekaly; Jay A Levy; Jürgen K Rockstroh; Philip J Goulder; Bruce D Walker
Journal:  AIDS       Date:  2003-12-05       Impact factor: 4.177

Review 2.  HIV and SIV CTL escape: implications for vaccine design.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

3.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

4.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.

Authors:  Jianming Tang; Shenghui Tang; Elena Lobashevsky; Angela D Myracle; Ulgen Fideli; Grace Aldrovandi; Susan Allen; Rosemary Musonda; Richard A Kaslow
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells.

Authors:  Hendrik Streeck; Jonathan S Jolin; Ying Qi; Bader Yassine-Diab; Randall C Johnson; Douglas S Kwon; Marylyn M Addo; Chanson Brumme; Jean-Pierre Routy; Susan Little; Heiko K Jessen; Anthony D Kelleher; Frederick M Hecht; Rafick-Pierre Sekaly; Eric S Rosenberg; Bruce D Walker; Mary Carrington; Marcus Altfeld
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

7.  Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection.

Authors:  Emma L Turnbull; MaiLee Wong; Shuyi Wang; Xiping Wei; Nicola A Jones; Karen E Conrod; Diana Aldam; Jo Turner; Pierre Pellegrino; Brandon F Keele; Ian Williams; George M Shaw; Persephone Borrow
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

8.  Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication.

Authors:  Bianca R Mothé; Jason Weinfurter; Chenxi Wang; William Rehrauer; Nancy Wilson; Todd M Allen; David B Allison; David I Watkins
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques.

Authors:  Tetsuo Tsukamoto; Akiko Takeda; Takuya Yamamoto; Hiroyuki Yamamoto; Miki Kawada; Tetsuro Matano
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

10.  Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.

Authors:  Tetsuro Matano; Masahiro Kobayashi; Hiroko Igarashi; Akiko Takeda; Hiromi Nakamura; Munehide Kano; Chie Sugimoto; Kazuyasu Mori; Akihiro Iida; Takahiro Hirata; Mamoru Hasegawa; Takae Yuasa; Masaaki Miyazawa; Yumiko Takahashi; Michio Yasunami; Akinori Kimura; David H O'Connor; David I Watkins; Yoshiyuki Nagai
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

View more
  11 in total

1.  Lineage-specific evolution of T-cell immunoglobulin and mucin domain 1 gene in the primates.

Authors:  Hitoshi Ohtani; Taeko K Naruse; Yuki Iwasaki; Hirofumi Akari; Takafumi Ishida; Tetsuro Matano; Akinori Kimura
Journal:  Immunogenetics       Date:  2012-06-19       Impact factor: 2.846

Review 2.  HIV and HLA class I: an evolving relationship.

Authors:  Philip J R Goulder; Bruce D Walker
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

3.  A Novel Immunogen Selectively Eliciting CD8+ T Cells but Not CD4+ T Cells Targeting Immunodeficiency Virus Antigens.

Authors:  Hiroshi Ishii; Kazutaka Terahara; Takushi Nomura; Akiko Takeda; Midori Okazaki; Hiroyuki Yamamoto; Tsuyoshi Tokusumi; Tsugumine Shu; Tetsuro Matano
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

4.  Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.

Authors:  Philippa C Matthews; Madoka Koyanagi; Henrik N Kløverpris; Mikkel Harndahl; Anette Stryhn; Tomohiro Akahoshi; Hiroyuki Gatanaga; Shinichi Oka; Claudia Juarez Molina; Humberto Valenzuela Ponce; Santiago Avila Rios; David Cole; Jonathan Carlson; Rebecca P Payne; Anthony Ogwu; Alfred Bere; Thumbi Ndung'u; Kamini Gounder; Fabian Chen; Lynn Riddell; Graz Luzzi; Roger Shapiro; Christian Brander; Bruce Walker; Andrew K Sewell; Gustavo Reyes Teran; David Heckerman; Eric Hunter; Søren Buus; Masafumi Takiguchi; Philip J R Goulder
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

5.  Association of major histocompatibility complex class I haplotypes with disease progression after simian immunodeficiency virus challenge in burmese rhesus macaques.

Authors:  Takushi Nomura; Hiroyuki Yamamoto; Teiichiro Shiino; Naofumi Takahashi; Taku Nakane; Nami Iwamoto; Hiroshi Ishii; Tetsuo Tsukamoto; Miki Kawada; Saori Matsuoka; Akiko Takeda; Kazutaka Terahara; Yasuko Tsunetsugu-Yokota; Naoko Iwata-Yoshikawa; Hideki Hasegawa; Tetsutaro Sata; Taeko K Naruse; Akinori Kimura; Tetsuro Matano
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

6.  Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.

Authors:  Sumire Iseda; Naofumi Takahashi; Hugo Poplimont; Takushi Nomura; Sayuri Seki; Taku Nakane; Midori Nakamura; Shoi Shi; Hiroshi Ishii; Shota Furukawa; Shigeyoshi Harada; Taeko K Naruse; Akinori Kimura; Tetsuro Matano; Hiroyuki Yamamoto
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

7.  Computational B-cell epitope identification and production of neutralizing murine antibodies against Atroxlysin-I.

Authors:  Edgar Ernesto Gonzalez Kozlova; Loïc Cerf; Francisco Santos Schneider; Benjamin Thomas Viart; Christophe NGuyen; Bethina Trevisol Steiner; Sabrina de Almeida Lima; Franck Molina; Clara Guerra Duarte; Liza Felicori; Carlos Chávez-Olórtegui; Ricardo Andrez Machado-de-Ávila
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

8.  Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice.

Authors:  Anne-Marie Carola Andersson; Peter Johannes Holst
Journal:  J Transl Med       Date:  2016-12-20       Impact factor: 5.531

9.  A novel protective MHC-I haplotype not associated with dominant Gag-specific CD8+ T-cell responses in SIVmac239 infection of Burmese rhesus macaques.

Authors:  Naofumi Takahashi; Takushi Nomura; Yusuke Takahara; Hiroyuki Yamamoto; Teiichiro Shiino; Akiko Takeda; Makoto Inoue; Akihiro Iida; Hiroto Hara; Tsugumine Shu; Mamoru Hasegawa; Hiromi Sakawaki; Tomoyuki Miura; Tatsuhiko Igarashi; Yoshio Koyanagi; Taeko K Naruse; Akinori Kimura; Tetsuro Matano
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Broadening of Virus-Specific CD8+ T-Cell Responses Is Indicative of Residual Viral Replication in Aviremic SIV Controllers.

Authors:  Takushi Nomura; Hiroyuki Yamamoto; Hiroshi Ishii; Hirofumi Akari; Taeko K Naruse; Akinori Kimura; Tetsuro Matano
Journal:  PLoS Pathog       Date:  2015-11-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.